Search

Oxford Silk Phage Technology, in collaboration with the University of Exeter and the University of Hertfordshire, has been awarded 2 million British pounds via a new Collaborative Innovate UK Biomedical Catalyst grant. The funds will accele

We are urgently seeking Staphylococcus epidermidis phages for a patient in the UK. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By

We are urgently seeking Staphylococcus epidermidis phages for a patient in the UK. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By

Medea Biopharma GmbH, a German phage therapy company, is hiring a principal investigator to run their BSL2 microbiology lab.

Canadian phage therapy biotech Cytophage Technologies and Cuspis Capital III Ltd. have announced a business combination agreement and concurrent financing. This means additional funds for Cytophage as it develops phage therapy for human and

We are urgently seeking Burkholderia multivorans phages for a cystic fibrosis patient in France Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your

We are urgently seeking Burkholderia multivorans phages for a cystic fibrosis patient in France Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your

Kiran Bosco (Westmead Institute for Medical Research) and colleagues have reviewed the topic of therapeutic phage monitoring, proposed as an essential element of phage therapy protocols to generate data and fill knowledge gaps regarding the

Jean-Paul Pirnay and colleagues explore the question of whether magistral phage preparations could serve as a model for everyone.

Armata Pharmaceuticals will present positive topline data from the SWARM-P.a. clinical study at the North American Cystic Fibrosis Conference November 3rd in Phoenix, AZ, highlighting results of their novel inhaled multi-phage therapeutic f

Antonia Sagona (University of Warwick, UK) is seeking a PhD student to study phage isolation and characterization for clinical applications.

UK-based phage biotech company Fixed Phage has changed its name to NexaBiome Limited, to reflect its new focus as an end-to-end phage company in the human and animal health sectors.

FDA, USA is hiring a Postdoctoral Fellow to develop and characterize a phage therapy to decolonize vancomycin-resistant Enterococci.

Shawna McCallin and colleagues from ESGNTA-ESCMID study group published an overview of the current status and emerging use of phage therapy and phage-based products, as well as the socioeconomic and regulatory issues surrounding their devel

Phage Futures: Global Digital Summit is happening October 25, 2023, and will focus on accelerating the translation of phages into viable therapeutics and commercial solutions. Book your free pass here!

Intralytix, Inc. has been issued a patent by the European Patent Office for several Shigella phages and their applications and formulations.

The European Medicines Agency have published a new guideline on the quality, safety, and efficacy of phages as veterinary medicines.

UT Health, Houston, USA, is hiring a postdoc to perform experiments in the area of cell and molecular biology, molecular virology, and immunology relating to T cells gene editing, HIV gene therapy and/or phage therapy for multi drug-resista

UCSD will soon open as a clinical trial site for Adaptive Phage Therapeutics' ACTIVE.2 trial, studying the safety and efficacy of APT's Phage Bank versus placebo in patients with prosthetic joint infections.

We are urgently seeking Staphylococcus epidermidis phages for a patient in Canada Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your phages - By h